Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy

H. Müllerová (Uxbridge, United Kingdom), C. El-Baou (Uxbridge, United Kingdom), D. Galkin (Research Triangle Park, United States of America), P. Jones (Brentford, United Kingdom)

Source: International Congress 2018 – Innovative therapies in asthma and COPD
Session: Innovative therapies in asthma and COPD
Session type: Poster Discussion
Number: 614
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Müllerová (Uxbridge, United Kingdom), C. El-Baou (Uxbridge, United Kingdom), D. Galkin (Research Triangle Park, United States of America), P. Jones (Brentford, United Kingdom). Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy. 614

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019

Risk of Haemophilus Influenzae Infection in Patients with Chronic Obstructive Pulmonary Disease Using Inhaled Corticosteroids: A Cohort Study of 23,789 Outpatients.
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019



Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018


LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014


Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Rhinovirus Challenge in Asthmatics and Healthy Volunteers to Evaluate the Safety and Appropriate Dose of a GMP Human Rhinovirus 16 Preparation for Challenge Studies in Mild-Moderate Asthmatics taking ICS
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

Variability in Blood Eosinophils: Findings from the WATCH Cohort of Difficult Asthma
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019

Prescribing Trends of Oral Corticosteroids Among Young Adults with Active Asthma
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


1-?-alkyl-glycerols Reduce Level of Inflammatory Cytokines In Obese Asthma
Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies
Year: 2021


FENO Guided Therapy in Asthma: A Non-inferiority Study
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019



Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019


Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021

Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Associated Factors with the Approval of Pulmonary Rehabilitation for Inpatients with Interstitial Lung Disease: Two-center Retrospective Study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Late Breaking Abstract -  Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Short-term Impact of Lung Flute and Inspiratory Muscle Trainer on Pulmonary Functions and Functional Capacity in COPD from a Low Middle Income Country : A Pilot Randomized Control Trial.
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017